Farther Finance Advisors LLC Sells 1,035 Shares of CME Group Inc. (NASDAQ:CME)

Farther Finance Advisors LLC cut its holdings in shares of CME Group Inc. (NASDAQ:CME) by 16.7% during the third quarter, Holdings Channel reports. The fund owned 5,160 shares of the financial services provider’s stock after selling 1,035 shares during the quarter. Farther Finance Advisors LLC’s holdings in CME Group were worth $1,138,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in CME. Capital International Investors increased its holdings in shares of CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. grew its stake in CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after buying an additional 1,309,097 shares during the last quarter. M&G Plc acquired a new stake in CME Group during the first quarter worth approximately $156,631,000. Assenagon Asset Management S.A. lifted its position in CME Group by 577.9% during the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after acquiring an additional 550,133 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its holdings in shares of CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after acquiring an additional 537,758 shares during the period. Institutional investors own 87.75% of the company’s stock.

CME Group Trading Down 0.8 %

Shares of CME stock opened at $223.61 on Monday. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The stock’s fifty day moving average price is $220.69 and its two-hundred day moving average price is $209.49. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market cap of $80.52 billion, a PE ratio of 23.51, a P/E/G ratio of 5.67 and a beta of 0.55.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the firm posted $2.25 earnings per share. CME Group’s revenue was up 18.4% compared to the same quarter last year. Equities analysts predict that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.06%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Insider Buying and Selling

In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of the firm’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares in the company, valued at $1,652,298. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, insider Sunil Cutinho sold 4,500 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total value of $1,019,880.00. Following the completion of the transaction, the insider now owns 27,053 shares in the company, valued at $6,131,291.92. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the sale, the insider now owns 7,275 shares in the company, valued at approximately $1,652,298. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,221 shares of company stock worth $3,351,895 in the last three months. 0.30% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on CME. Bank of America lifted their price target on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. TD Cowen started coverage on shares of CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Citigroup raised their price target on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Finally, The Goldman Sachs Group raised their target price on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus target price of $222.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.